| Cat. No. |
Product Name |
Information |
| PC-63032 |
ABT-288
Histamine H3 antagonist
|
ABT-288 is a potent, selective and competitive antagonist of H3 receptor with Ki of 1.9/8.2 nM for human/rat H3 respectively. |
| PC-61996 |
LY2624803
H1R/5-HT2A modulator
|
LY2624803 is a novel potent histamine H1 and 5-HT2A receptor modulator in the pipeline for treating insomnia. |
| PC-61663 |
JNJ-10181457 dihydrochloride
Histamine H3 antagonist
|
JNJ-10181457 dihydrochloride is a neutral, potent and selective, brain penetrant H3 antagonist with pKi of 8.93, pA2 of 9.22 for hH3. |
| PC-61662 |
JNJ-10181457
Histamine H3 antagonist
|
JNJ-10181457 is a neutral, potent and selective, brain penetrant H3 antagonist with pKi of 8.93, pA2 of 9.22 for hH3. |
| PC-61661 |
JNJ-39220675
H3R antagonist
|
JNJ-39220675 is potent and selective, brain penetrant histamine H3 receptor (H3R) antagonist with Ki of 1.4 nM, pA2 of 9.42 for hH3. |
| PC-61616 |
Irdabisant hydrochloride
H3 receptor antagonist
|
Irdabisant (CEP-26401) hydrochloride is a potent, selective, orally active histamine H3 receptor antagonist with Ki of 2 nM and 7 nM for human and rat H3Rs, respectivity. |
| PC-61615 |
Irdabisant
H3 receptor antagonist
|
Irdabisant (CEP-26401) is a potent, selective, orally active histamine H3 receptor antagonist with Ki of 2 nM and 7 nM for human and rat H3Rs, respectivity. |
| PC-61569 |
Burimamide oxalate
H3/H2 receptor antagonist
|
Burimamide oxalate is a potent dual H3/H2 receptor antagonist with Ki of 0.07 and 7.8 uM, respectively. |
| PC-61568 |
Burimamide
H3/H2 receptor antagonist
|
Burimamide is a potent dual H3/H2 receptor antagonist with Ki of 0.07 and 7.8 uM, respectively. |
| PC-61567 |
Adriforant
Histamine H4 antagonist
|
Adriforant (PF-3893787, ZPL-3893787) is a potent and selective H4 receptor antagonist with binding Ki of 2.4 nM. |
| PC-61562 |
APD916
Histamine H3 antagonist
|
APD916 is a potent and selective antagonist of the H3 receptor with Ki of 0.7 nM for rH3R. |
| PC-61337 |
MK-7288
H3R inverse agonist
|
MK-7288 is a selective histamine H3 receptor inverse agonist for the treatment of sleep apnoea syndrome. |